$1.5 Billion is the total value of SABBY MANAGEMENT, LLC's 169 reported holdings in Q2 2013. The portfolio turnover from Q1 2013 to Q2 2013 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | VERTEX PHARMACEUTICALS INCcall | $184,220,000 | – | 23,065 | +100.0% | 12.30% | – | |
| New | SPDR S&P 500 ETF TRUSTput | $72,005,000 | – | 4,500 | +100.0% | 4.81% | – | |
| New | MERCK & CO INCcall | $61,523,000 | – | 13,245 | +100.0% | 4.11% | – | |
| New | CELGENE CORPcall | $55,789,000 | – | 4,772 | +100.0% | 3.72% | – | |
| New | ELI LILLY & COcall | $50,289,000 | – | 10,238 | +100.0% | 3.36% | – | |
| IWM | New | ISHARES RUSSELL 2000 INDEX FUNDput | $48,580,000 | – | 5,000 | +100.0% | 3.24% | – |
| New | REGENERON PHARMACEUTICALS INCcall | $48,057,000 | – | 2,137 | +100.0% | 3.21% | – | |
| New | ACADIA PHARMACEUTICALS INCcall | $45,705,000 | – | 25,182 | +100.0% | 3.05% | – | |
| New | VERTEX PHARMACEUTICALS INCput | $41,988,000 | – | 5,257 | +100.0% | 2.80% | – | |
| New | GILEAD SCIENCES INCput | $38,561,000 | – | 7,530 | +100.0% | 2.57% | – | |
| New | ABBVIE INCput | $38,252,000 | – | 9,253 | +100.0% | 2.55% | – | |
| AEGR | New | AEGERION PHARMACEUTICALS INC | $37,615,000 | – | 593,862 | +100.0% | 2.51% | – |
| New | CYBERONICS INCput | $30,911,000 | – | 5,949 | +100.0% | 2.06% | – | |
| New | ALLERGAN INCcall | $30,318,000 | – | 3,599 | +100.0% | 2.02% | – | |
| New | PERRIGO COcall | $27,104,000 | – | 2,240 | +100.0% | 1.81% | – | |
| New | MANNKIND CORPcall | $25,221,000 | – | 38,801 | +100.0% | 1.68% | – | |
| New | ASTRAZENECA PLC - ADRcall | $22,841,000 | – | 4,829 | +100.0% | 1.52% | – | |
| New | ISHARES 20+ YEAR TREASURYput | $22,088,000 | – | 2,000 | +100.0% | 1.47% | – | |
| New | ONYX PHARMACEUTICALS INCcall | $21,454,000 | – | 2,470 | +100.0% | 1.43% | – | |
| New | SAREPTA THERAPEUTICS INCput | $20,817,000 | – | 5,471 | +100.0% | 1.39% | – | |
| SRPT | New | SAREPTA THERAPEUTICS INC | $17,309,000 | – | 454,899 | +100.0% | 1.16% | – |
| New | ZOETIS INCput | $16,962,000 | – | 5,491 | +100.0% | 1.13% | – | |
| New | BAXTER INTERNATIONAL INCcall | $16,909,000 | – | 2,441 | +100.0% | 1.13% | – | |
| New | AEGERION PHARMACEUTICALS INCput | $15,012,000 | – | 2,370 | +100.0% | 1.00% | – | |
| ABBV | New | ABBVIE INC | $14,702,000 | – | 355,626 | +100.0% | 0.98% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $14,597,000 | – | 804,255 | +100.0% | 0.97% | – |
| ZTS | New | ZOETIS INCcl a | $14,210,000 | – | 460,030 | +100.0% | 0.95% | – |
| New | GILEAD SCIENCES INCcall | $13,857,000 | – | 2,706 | +100.0% | 0.92% | – | |
| New | REGENERON PHARMACEUTICALS INCput | $12,751,000 | – | 567 | +100.0% | 0.85% | – | |
| New | WELLPOINT INCcall | $12,693,000 | – | 1,551 | +100.0% | 0.85% | – | |
| New | WELLPOINT INCput | $12,693,000 | – | 1,551 | +100.0% | 0.85% | – | |
| New | VALEANT PHARMACEUTICALS INTERNATIONALcall | $12,266,000 | – | 1,425 | +100.0% | 0.82% | – | |
| New | ABBVIE INCcall | $12,096,000 | – | 2,926 | +100.0% | 0.81% | – | |
| New | ELAN CORPORATION PLC - ADRcall | $11,777,000 | – | 8,329 | +100.0% | 0.79% | – | |
| TLT | New | ISHARES 20+ YEAR TREASURY | $11,491,000 | – | 104,050 | +100.0% | 0.77% | – |
| New | EDWARDS LIFESCIENCES CORPcall | $11,411,000 | – | 1,698 | +100.0% | 0.76% | – | |
| New | MYRIAD GENETICS INCcall | $11,087,000 | – | 4,126 | +100.0% | 0.74% | – | |
| New | ACORDA THERAPEUTICS INCcall | $10,748,000 | – | 3,258 | +100.0% | 0.72% | – | |
| New | WELLCARE HEALTH PLANS INCcall | $10,027,000 | – | 1,805 | +100.0% | 0.67% | – | |
| GILD | New | GILEAD SCIENCES INC | $8,916,000 | – | 174,108 | +100.0% | 0.60% | – |
| New | SAREPTA THERAPEUTICS INCcall | $8,595,000 | – | 2,259 | +100.0% | 0.57% | – | |
| CYBX | New | CYBERONICS INC | $8,450,000 | – | 162,625 | +100.0% | 0.56% | – |
| New | ARENA PHARMACEUTICALS INCcall | $7,865,000 | – | 10,214 | +100.0% | 0.52% | – | |
| New | NEWLINK GENETICS CORPcall | $7,825,000 | – | 3,968 | +100.0% | 0.52% | – | |
| New | BRISTOL MYERS SQUIBB COcall | $7,575,000 | – | 1,695 | +100.0% | 0.51% | – | |
| New | TEVA PHARMACEUTICAL INDUSTRIESput | $7,428,000 | – | 1,895 | +100.0% | 0.50% | – | |
| New | ARENA PHARMACEUTICALS INCput | $7,236,000 | – | 9,398 | +100.0% | 0.48% | – | |
| New | AEGERION PHARMACEUTICALS INCcall | $7,189,000 | – | 1,135 | +100.0% | 0.48% | – | |
| ANTH | New | ANTHERA PHARMACEUTICALS INC | $7,066,000 | – | 15,259,074 | +100.0% | 0.47% | – |
| New | KERYX BIOPHARMACEUTICALSput | $6,880,000 | – | 9,210 | +100.0% | 0.46% | – | |
| New | CELGENE CORPput | $6,711,000 | – | 574 | +100.0% | 0.45% | – | |
| New | MEDIVATION INCput | $6,219,000 | – | 1,264 | +100.0% | 0.42% | – | |
| AUXL | New | AUXILIUM PHARMACEUTICALS INCcall | $6,205,000 | – | 3,731 | +100.0% | 0.41% | – |
| New | CUBIST PHARMACEUTICALS INCcall | $6,168,000 | – | 1,277 | +100.0% | 0.41% | – | |
| NS | New | NUSTAR ENERGY LPcall | $6,163,000 | – | 1,350 | +100.0% | 0.41% | – |
| New | ACHILLION PHARMACEUTICALS INCcall | $6,119,000 | – | 7,480 | +100.0% | 0.41% | – | |
| New | MANNKIND CORPput | $5,824,000 | – | 8,960 | +100.0% | 0.39% | – | |
| KERX | New | KERYX BIOPHARMACEUTICALS | $5,568,000 | – | 745,435 | +100.0% | 0.37% | – |
| New | COPART INCcall | $5,541,000 | – | 1,799 | +100.0% | 0.37% | – | |
| New | BRIDGEPOINT EDUCATION INCput | $5,335,000 | – | 4,380 | +100.0% | 0.36% | – | |
| New | NEUROCRINE BIOSCIENCES INCcall | $5,166,000 | – | 3,861 | +100.0% | 0.34% | – | |
| New | ENDO HEALTH SOLUTIONS INCput | $5,129,000 | – | 1,394 | +100.0% | 0.34% | – | |
| New | AMARIN CORPORATION PLC -ADRcall | $4,938,000 | – | 8,513 | +100.0% | 0.33% | – | |
| ARWR | New | ARROWHEAD RESEARCH CORP | $4,554,000 | – | 2,276,980 | +100.0% | 0.30% | – |
| New | OREXIGEN THERAPEUTICS INCcall | $4,447,000 | – | 7,602 | +100.0% | 0.30% | – | |
| New | LINN ENERGY LLC PARTNERSHIP UNITcall | $4,370,000 | – | 1,317 | +100.0% | 0.29% | – | |
| New | TEVA PHARMACEUTICAL INDUSTRIEScall | $4,363,000 | – | 1,113 | +100.0% | 0.29% | – | |
| New | REPROS THERAPEUTICS INCput | $4,325,000 | – | 2,344 | +100.0% | 0.29% | – | |
| New | ALLERGAN INCput | $4,254,000 | – | 505 | +100.0% | 0.28% | – | |
| New | MYRIAD GENETICS INCput | $4,122,000 | – | 1,534 | +100.0% | 0.28% | – | |
| New | AMARIN CORPORATION PLC -ADRput | $3,921,000 | – | 6,761 | +100.0% | 0.26% | – | |
| OGXI | New | ONCOGENEX PHARMACEUTICAL | $3,888,000 | – | 396,730 | +100.0% | 0.26% | – |
| New | BRIDGEPOINT EDUCATION INCcall | $3,812,000 | – | 3,130 | +100.0% | 0.25% | – | |
| New | ZOETIS INCcall | $3,784,000 | – | 1,225 | +100.0% | 0.25% | – | |
| New | MEDIVATION INCcall | $3,715,000 | – | 755 | +100.0% | 0.25% | – | |
| New | THERAVANCE INCcall | $3,660,000 | – | 950 | +100.0% | 0.24% | – | |
| New | ALEXION PHARMACEUTICALS INCcall | $3,588,000 | – | 389 | +100.0% | 0.24% | – | |
| MSTX | New | MAST THERAPEUTICS INC | $3,310,000 | – | 7,711,867 | +100.0% | 0.22% | – |
| New | ALIGN TECHNOLOGY INCcall | $3,293,000 | – | 889 | +100.0% | 0.22% | – | |
| EDAP | New | EDAP TMS SA -ADRadr | $3,268,000 | – | 1,197,086 | +100.0% | 0.22% | – |
| New | INTERMUNE INCcall | $3,121,000 | – | 3,244 | +100.0% | 0.21% | – | |
| New | OPKO HEALTH INCput | $3,011,000 | – | 4,241 | +100.0% | 0.20% | – | |
| New | SOLAZYME INCcall | $3,004,000 | – | 2,563 | +100.0% | 0.20% | – | |
| NWBO | New | NORTHWEST BIOTHERAPEUTICS | $2,908,000 | – | 870,543 | +100.0% | 0.19% | – |
| New | DENDREON CORPcall | $2,809,000 | – | 6,819 | +100.0% | 0.19% | – | |
| New | ISIS PHARMACEUTICALS INC SHScall | $2,714,000 | – | 1,010 | +100.0% | 0.18% | – | |
| New | MAKO SURGICAL CORPcall | $2,645,000 | – | 2,195 | +100.0% | 0.18% | – | |
| New | VIVUS INCcall | $2,568,000 | – | 2,041 | +100.0% | 0.17% | – | |
| ENMD | New | ENTREMED INC | $2,369,000 | – | 1,172,590 | +100.0% | 0.16% | – |
| New | ONYX PHARMACEUTICALS INCput | $2,354,000 | – | 271 | +100.0% | 0.16% | – | |
| MDVN | New | MEDIVATION INC | $2,357,000 | – | 47,900 | +100.0% | 0.16% | – |
| New | INSMED INCcall | $2,243,000 | – | 1,875 | +100.0% | 0.15% | – | |
| New | ELI LILLY & COput | $1,999,000 | – | 407 | +100.0% | 0.13% | – | |
| New | SOLAZYME INCput | $1,808,000 | – | 1,543 | +100.0% | 0.12% | – | |
| New | ACHILLION PHARMACEUTICALS INCput | $1,773,000 | – | 2,167 | +100.0% | 0.12% | – | |
| New | ROCKWELL MEDICAL INCcall | $1,747,000 | – | 4,839 | +100.0% | 0.12% | – | |
| New | ONCOGENEX PHARMACEUTICALput | $1,735,000 | – | 1,770 | +100.0% | 0.12% | – | |
| VTUS | New | VENTRUS BIOSCIENCES INC | $1,669,000 | – | 695,400 | +100.0% | 0.11% | – |
| MDGN | New | MEDGENICS INC | $1,625,000 | – | 427,684 | +100.0% | 0.11% | – |
| New | INTERMUNE INCput | $1,625,000 | – | 1,689 | +100.0% | 0.11% | – | |
| New | VIVUS INCput | $1,510,000 | – | 1,200 | +100.0% | 0.10% | – | |
| New | ALNYLAM PHARMACEUTICALS INCcall | $1,451,000 | – | 468 | +100.0% | 0.10% | – | |
| AMRN | New | AMARIN CORPORATION PLC -ADRadr | $1,457,000 | – | 251,271 | +100.0% | 0.10% | – |
| New | NEUROCRINE BIOSCIENCES INCput | $1,412,000 | – | 1,055 | +100.0% | 0.09% | – | |
| NS | New | NUSTAR ENERGY LPput | $1,379,000 | – | 302 | +100.0% | 0.09% | – |
| New | MERCK & CO INCput | $1,361,000 | – | 293 | +100.0% | 0.09% | – | |
| New | BIODEL INCcall | $1,271,000 | – | 3,041 | +100.0% | 0.08% | – | |
| ABIO | New | ARCA BIOPHARMA INC | $1,276,000 | – | 988,934 | +100.0% | 0.08% | – |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $1,207,000 | – | 15,108 | +100.0% | 0.08% | – |
| CEMP | New | CEMPRA INC | $1,175,000 | – | 150,000 | +100.0% | 0.08% | – |
| AVNR | New | AVANIR PHARMACEUTICALS INC | $1,150,000 | – | 250,000 | +100.0% | 0.08% | – |
| RPRX | New | REPROS THERAPEUTICS INC | $1,146,000 | – | 62,090 | +100.0% | 0.08% | – |
| New | SYNTA PHARMACEUTICALS CORPput | $1,087,000 | – | 2,179 | +100.0% | 0.07% | – | |
| New | INFINITY PHARMACEUTICALScall | $1,082,000 | – | 666 | +100.0% | 0.07% | – | |
| NS | New | NUSTAR ENERGY LPunit | $1,077,000 | – | 23,584 | +100.0% | 0.07% | – |
| SNTA | New | SYNTA PHARMACEUTICALS CORP | $1,079,000 | – | 216,268 | +100.0% | 0.07% | – |
| New | SUNESIS PHARMACEUTICALS INCput | $1,042,000 | – | 2,000 | +100.0% | 0.07% | – | |
| New | VICAL INCcall | $1,030,000 | – | 3,291 | +100.0% | 0.07% | – | |
| New | ASTEX PHARMACEUTICALS INCcall | $948,000 | – | 2,307 | +100.0% | 0.06% | – | |
| New | INCYTE CORPcall | $948,000 | – | 431 | +100.0% | 0.06% | – | |
| SNSS | New | SUNESIS PHARMACEUTICALS INC | $939,000 | – | 180,300 | +100.0% | 0.06% | – |
| TXMD | New | THERAPEUTICSMD INC | $944,000 | – | 311,584 | +100.0% | 0.06% | – |
| LLY | New | ELI LILLY & CO | $895,000 | – | 18,222 | +100.0% | 0.06% | – |
| New | ALEXZA PHARMACEUTICALS INCcall | $890,000 | – | 2,050 | +100.0% | 0.06% | – | |
| New | UNI-PIXEL INCput | $871,000 | – | 592 | +100.0% | 0.06% | – | |
| New | ARIAD PHARMACEUTICALS INCput | $836,000 | – | 478 | +100.0% | 0.06% | – | |
| MNKD | New | MANNKIND CORP | $832,000 | – | 128,007 | +100.0% | 0.06% | – |
| TEVA | New | TEVA PHARMACEUTICAL INDUSTRIESadr | $813,000 | – | 20,736 | +100.0% | 0.05% | – |
| New | PBF ENERGY INCcall | $805,000 | – | 311 | +100.0% | 0.05% | – | |
| BAX | New | BAXTER INTERNATIONAL INC | $800,000 | – | 11,553 | +100.0% | 0.05% | – |
| New | MOMENTA PHARMACEUTICALS INCcall | $786,000 | – | 522 | +100.0% | 0.05% | – | |
| MEIP | New | MEI PHARMA INC | $760,000 | – | 106,600 | +100.0% | 0.05% | – |
| New | DENDREON CORPput | $700,000 | – | 1,700 | +100.0% | 0.05% | – | |
| New | KERYX BIOPHARMACEUTICALScall | $683,000 | – | 914 | +100.0% | 0.05% | – | |
| New | ZIOPHARM ONCOLOGY INCcall | $688,000 | – | 3,276 | +100.0% | 0.05% | – | |
| New | CELSION CORPORATIONcall | $659,000 | – | 6,462 | +100.0% | 0.04% | – | |
| TSPT | New | TRANSCEPT PHARMACEUTICALS | $610,000 | – | 202,036 | +100.0% | 0.04% | – |
| New | SYNERGY PHARMACEUTICALS WTScall | $610,000 | – | 331,486 | +100.0% | 0.04% | – | |
| NAVB | New | NAVIDEA BIOPHARMACEUTICALS INCcall | $603,000 | – | 2,260 | +100.0% | 0.04% | – |
| New | GTX INCcall | $578,000 | – | 876 | +100.0% | 0.04% | – | |
| New | TRANSCEPT PHARMACEUTICALSput | $523,000 | – | 1,732 | +100.0% | 0.04% | – | |
| New | ARIAD PHARMACEUTICALS INCcall | $514,000 | – | 294 | +100.0% | 0.03% | – | |
| ATHX | New | ATHERSYS INC | $499,000 | – | 300,745 | +100.0% | 0.03% | – |
| INFI | New | INFINITY PHARMACEUTICALS | $474,000 | – | 29,188 | +100.0% | 0.03% | – |
| New | PEREGRINE PHARMACEUTICALSput | $486,000 | – | 3,770 | +100.0% | 0.03% | – | |
| VNDA | New | VANDA PHARMACEUTICALS INC | $459,000 | – | 56,843 | +100.0% | 0.03% | – |
| New | ASTEX PHARMACEUTICALS INCput | $429,000 | – | 1,043 | +100.0% | 0.03% | – | |
| New | CORONADO BIOSCIENCES INCcall | $420,000 | – | 488 | +100.0% | 0.03% | – | |
| PPHM | New | PEREGRINE PHARMACEUTICALS | $385,000 | – | 298,200 | +100.0% | 0.03% | – |
| New | REPROS THERAPEUTICS INCcall | $369,000 | – | 200 | +100.0% | 0.02% | – | |
| NURO | New | NEUROMETRIX INC | $357,000 | – | 178,387 | +100.0% | 0.02% | – |
| CRDC | New | CARDICA INC | $354,000 | – | 318,984 | +100.0% | 0.02% | – |
| New | TARGACEPT INCcall | $352,000 | – | 824 | +100.0% | 0.02% | – | |
| New | VICAL INCput | $325,000 | – | 1,038 | +100.0% | 0.02% | – | |
| New | LINN ENERGY LLC PARTNERSHIP UNITput | $332,000 | – | 100 | +100.0% | 0.02% | – | |
| New | BIODEL INCput | $322,000 | – | 771 | +100.0% | 0.02% | – | |
| LPTN | New | LPATH INC | $312,000 | – | 70,907 | +100.0% | 0.02% | – |
| New | PEREGRINE PHARMACEUTICALScall | $320,000 | – | 2,478 | +100.0% | 0.02% | – | |
| QLTI | New | QLT INC | $295,000 | – | 67,300 | +100.0% | 0.02% | – |
| New | ROCKWELL MEDICAL INCput | $304,000 | – | 842 | +100.0% | 0.02% | – | |
| New | GALENA BIOPHARMA INCput | $287,000 | – | 1,291 | +100.0% | 0.02% | – | |
| New | CORONADO BIOSCIENCES INCput | $283,000 | – | 329 | +100.0% | 0.02% | – | |
| New | OREXIGEN THERAPEUTICS INCput | $255,000 | – | 436 | +100.0% | 0.02% | – | |
| PTN | New | PALATIN TECHNOLOGIES INC | $257,000 | – | 427,609 | +100.0% | 0.02% | – |
| NSPR | New | INSPIREMD INC | $235,000 | – | 106,800 | +100.0% | 0.02% | – |
| ARAY | New | ACCURAY INC | $244,000 | – | 42,491 | +100.0% | 0.02% | – |
| New | CELSION CORPORATIONput | $235,000 | – | 2,302 | +100.0% | 0.02% | – | |
| EXEL | New | EXELIXIS INCcall | $217,000 | – | 478 | +100.0% | 0.01% | – |
| New | CERUS CORPcall | $211,000 | – | 477 | +100.0% | 0.01% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
| ISHARES TR | 35 | Q3 2023 | 52.2% |
| SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
| AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
| BIOGEN INC | 24 | Q1 2021 | 26.2% |
| SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
| BIOGEN INC | 23 | Q1 2021 | 13.7% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
| BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
| VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
| Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
| Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
| Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
| HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
| PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
| Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
| TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
| Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
| TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.